Schmidt, Remo S.; Pereira de Macêdo, Juan; Steinmann, Michael Eduard; González Salgado, Amaia; Bütikofer, Peter; Sigel, Erwin; Rentsch, Doris; Mäser, Pascal (2018). Transporters of Trypanosoma brucei -phylogeny, physiology, pharmacology. FEBS journal, 285(6), pp. 1012-1023. Wiley 10.1111/febs.14302
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
2018_FEBSJ_285_1012.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (899kB) |
Trypanosoma brucei comprise the causative agents of sleeping sickness, T. b. gambiense and T. b. rhodesiense, as well as the livestock-pathogenic T. b. brucei. The parasites are transmitted by the tsetse fly and occur exclusively in sub-Saharan Africa. T. brucei are not only lethal pathogens but have also become model organisms for molecular parasitology. We focus here on membrane transport proteins of T. brucei, their contribution to homeostasis and metabolism in the context of a parasitic lifestyle, and their pharmacological role as potential drug targets or routes of drug entry. Transporters and channels in the plasma membrane are attractive drug targets as they are accessible from the outside. Alternatively, they can be exploited to selectively deliver harmful substances into the trypanosome's interior. Both approaches require the targeted transporter to be essential: in the first case to kill the trypanosome, in the second case to prevent drug resistance due to loss of the transporter. By combining functional and phylogenetic analyses, we were mining the T. brucei predicted proteome for transporters of pharmacological significance. Here, we review recent progress in the identification of transporters of lipid precursors, amino acid permeases and ion channels in T. brucei.
Actions (login required)
 |
Edit item |